Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) SVP Emily Dreyer sold 3,100 shares of the stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $54.85, for a total transaction of $170,035.00. Following the transaction, the senior vice president now owns 24,708 shares in the company, valued at approximately $1,355,233.80. The trade was a 11.15 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Emily Dreyer also recently made the following trade(s):
- On Monday, November 25th, Emily Dreyer sold 900 shares of Trupanion stock. The shares were sold at an average price of $54.55, for a total value of $49,095.00.
Trupanion Stock Down 1.6 %
TRUP stock opened at $53.50 on Friday. The stock has a market capitalization of $2.27 billion, a P/E ratio of -167.19 and a beta of 1.69. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. The firm has a 50-day moving average price of $49.73 and a 200-day moving average price of $40.06. Trupanion, Inc. has a 12 month low of $19.69 and a 12 month high of $57.90.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on TRUP shares. Piper Sandler raised their price objective on Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a research note on Thursday, October 31st. Bank of America raised their price target on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research report on Friday, September 20th. Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Northland Securities raised their target price on shares of Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a report on Thursday, October 31st. Finally, Stifel Nicolaus upped their price target on shares of Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a report on Monday, September 23rd. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $44.67.
Hedge Funds Weigh In On Trupanion
A number of institutional investors and hedge funds have recently bought and sold shares of the company. Wilmington Savings Fund Society FSB bought a new position in Trupanion in the third quarter valued at about $54,000. Barclays PLC raised its holdings in Trupanion by 259.2% in the 3rd quarter. Barclays PLC now owns 65,498 shares of the financial services provider’s stock valued at $2,750,000 after buying an additional 47,262 shares during the last quarter. DF Dent & Co. Inc. boosted its position in Trupanion by 27.8% during the 3rd quarter. DF Dent & Co. Inc. now owns 367,871 shares of the financial services provider’s stock worth $15,443,000 after buying an additional 80,014 shares during the period. Wellington Management Group LLP grew its holdings in Trupanion by 4.4% during the 3rd quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider’s stock worth $142,475,000 after acquiring an additional 142,156 shares during the last quarter. Finally, Weiss Asset Management LP acquired a new position in Trupanion in the 3rd quarter valued at approximately $855,000.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is the S&P/TSX Index?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is the Nasdaq? Complete Overview with History
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.